Is Allergan, Inc. FDA approved?

Allergan, Inc. holds 7 FDA-registered establishments across 3 countries. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.

Where are Allergan, Inc.'s drugs manufactured?

At registered sites in Belgium, Ireland, the United States. The FDA register lists Gr�ce-Hollogne; Carrowbeg Castlebar Road; Dublin; Campbell, CA; Cincinnati, OH; Irvine, CA, and 1 more. Registered operations: analytical testing, active ingredient (API) manufacture, labelling, finished drug manufacture, packaging.

What drugs does Allergan, Inc. make?

187 products are listed under Allergan, Inc. in the openFDA NDC Directory, most often as tablet; solution/ drops; tablet, film coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Allergan, Inc.

Data as of 28 Sept 2026 · How to read this entry

Request a quote Claim this profile

Registered sites: 7
Active NDC listings: 187
Live patents: 4
Countries: 3
Base: United States

Authorisation

Registered operations

Analytical testing7Active ingredient (API) manufacture2Labelling4Finished drug manufacture6Packaging4

Sites

Registered establishments

Establishment	Address	Registered for	FEI / DUNS
Odyssea Pharma SPRLRegistrant: Allergan, Inc.	Rue du travail, 16, Gr�ce-Hollogne, B-4460, Belgium (BEL)	Analytical testing, Labelling, Finished drug manufacture, Packaging	3007966308376598145
Allergan Pharmaceuticals IrelandRegistrant: Allergan, Inc.	Carrowbeg Castlebar Road, Westport, , Ireland (IRL)	Analytical testing, Labelling, Finished drug manufacture, Packaging	3002806285219682291
Forest Laboratories Ireland LimitedRegistrant: Allergan, Inc.	Clonshaugh Business & Technology, Clonshaugh, Dublin 17,, Dublin, D17 E400 , Ireland (IRL)	Analytical testing, Finished drug manufacture	3002806993896303588
Allergan Sales, LLCRegistrant: Allergan, Inc.	503 Vandell Way, Suite E, Campbell, California (CA) 95008, United States (USA)	Analytical testing, Active ingredient (API) manufacture	3000720089833024198
Allergan Sales, LLCRegistrant: Allergan, Inc.	5000 Brotherton Rd, Cincinnati, Ohio (OH) 45209-1105, United States (USA)	Analytical testing, Labelling, Finished drug manufacture, Packaging	1523957139645477
Allergan Sales, LLCRegistrant: Allergan, Inc.	2525 Dupont Drive, Irvine, California (CA) 92612, United States (USA)	Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture	2011068621001098
Pacific Pharma, Inc.Registrant: Allergan, Inc.	8301 Mars Drive, Waco, Texas (TX) 76712-6578, United States (USA)	Analytical testing, Labelling, Finished drug manufacture, Packaging	1643525078650213

Catalogue

Drug listings by form and route

187

187 active NDC listings: 99 human prescription drug, 51 drug for further processing, 36 human otc drug, 1 bulk ingredient. By marketing category: NDA 88, DRUG FOR FURTHER PROCESSING 51, OTC MONOGRAPH DRUG 33, UNAPPROVED DRUG OTHER 8, BLA 4.

Dosage form	NDCs
tablet	34
solution/ drops	32
tablet, film coated	28
capsule, gelatin coated	18
capsule, extended release	12
capsule	8
kit	7
gel	6
lotion	6
injection, powder, lyophilized, for solution	4
liquid	4
ointment	4
suspension/ drops	4
patch	3
powder, for solution	3

Route	NDCs
oral	57
ophthalmic	43
topical	10
intramuscular	5
intravenous	5
sublingual	3
vaginal	3
intradermal	2
rectal	2
transdermal	2
intracameral	1
intrauterine	1
intravitreal	1

Labeller name on the listing	NDCs
allergan, inc.	187

Exclusivity

Patents and exclusivities

Patent	Product	Covers	Expiry
7645459	ATELVIArisedronate sodium	product	Jan 2028
7645460	ATELVIArisedronate sodium	product	Jan 2028
7704984	LO LOESTRIN FE, LO MINASTRIN FEethinyl estradiol; norethindrone acetate	use	Feb 2029

Catalogue

Marketed products

187

Showing 150 of 187.

Brand	Generic name	Form / route	NDC
ACULAR LS	Ketorolac Tromethamine	solution/ drops, ophthalmic	0023-9277NDA
ACUVAIL	ketorolac tromethamine	solution/ drops, ophthalmic	0023-3507NDA
ACZONE	dapsone	gel, topical	0023-3670NDA
ALPHAGAN P	brimonidine tartrate	solution/ drops, ophthalmic	0023-9177NDA
ALPHAGAN P	brimonidine tartrate	solution/ drops, ophthalmic	0023-9321NDA
AVYCAZ	ceftazidime, avibactam	powder, for solution, intravenous	0456-2700NDA
Actonel	Risedronate Sodium	tablet, film coated, oral	0430-0472NDA
Actonel	Risedronate Sodium	tablet, film coated, oral	0430-0478NDA
Acular	Ketorolac Tromethamine	solution/ drops, ophthalmic	0023-2181NDA
Armour Thyroid	THYROID, PORCINE	tablet, oral	0456-0458UNAPPROVED DRUG OTHER
Armour Thyroid	THYROID, PORCINE	tablet, oral	0456-0459UNAPPROVED DRUG OTHER
Armour Thyroid	THYROID, PORCINE	tablet, oral	0456-0460UNAPPROVED DRUG OTHER
Armour Thyroid	THYROID, PORCINE	tablet, oral	0456-0461UNAPPROVED DRUG OTHER
Armour Thyroid	THYROID, PORCINE	tablet, oral	0456-0462UNAPPROVED DRUG OTHER
Armour Thyroid	THYROID, PORCINE	tablet, oral	0456-0463UNAPPROVED DRUG OTHER
Armour Thyroid	THYROID, PORCINE	tablet, oral	0456-0464UNAPPROVED DRUG OTHER
Armour Thyroid	THYROID, PORCINE	tablet, oral	0456-1045UNAPPROVED DRUG OTHER
-	Asenapine Maleate	tablet	0456-2404DRUG FOR FURTHER PROCESSING
-	Asenapine Maleate	tablet	0456-2407DRUG FOR FURTHER PROCESSING
-	Asenapine Maleate	tablet	0456-2412DRUG FOR FURTHER PROCESSING
Atelvia	risedronate sodium	tablet, delayed release, oral	0430-0979NDA
BOTOX	onabotulinumtoxinA	injection, powder, lyophilized, for solution, intradermal, intramuscular	0023-1145BLA
BOTOX	onabotulinumtoxinA	injection, powder, lyophilized, for solution, intradermal, intramuscular	0023-3921BLA
BOTOX Cosmetic	onabotulinumtoxinA	injection, powder, lyophilized, for solution, intramuscular	0023-3919BLA
BOTOX Cosmetic	onabotulinumtoxinA	injection, powder, lyophilized, for solution, intramuscular	0023-9232BLA
-	BOTULINUM TOXIN TYPE A	powder	0023-5027DRUG FOR FURTHER PROCESSING
Bystolic	nebivolol hydrochloride	tablet, oral	0456-1402NDA
Bystolic	nebivolol hydrochloride	tablet, oral	0456-1405NDA
Bystolic	nebivolol hydrochloride	tablet, oral	0456-1410NDA
Bystolic	nebivolol hydrochloride	tablet, oral	0456-1420NDA
COMBIGAN	brimonidine tartrate, timolol maleate	solution/ drops, ophthalmic	0023-9211NDA
Canasa	Mesalamine	suppository, rectal	58914-501NDA
Carafate	Sucralfate	suspension, oral	58914-170NDA
Carafate	Sucralfate	tablet, oral	58914-171NDA
-	Carboxymethylcellulose sodium	liquid	0023-8026DRUG FOR FURTHER PROCESSING
-	Carboxymethylcellulose sodium	liquid	0023-8027DRUG FOR FURTHER PROCESSING
Celexa	citalopram	tablet, film coated, oral	0456-4010NDA
Celexa	citalopram	tablet, film coated, oral	0456-4020NDA
Celexa	citalopram	tablet, film coated, oral	0456-4040NDA
Condylox	podofilox	gel, topical	0023-6118NDA
Crinone	progesterone	gel, vaginal	0023-6150NDA
Crinone	progesterone	gel, vaginal	0023-6151NDA
DALVANCE	Dalbavancin	injection, powder, for solution, intravenous	57970-100NDA
DURYSTA	bimatoprost	implant, intracameral	0023-9652NDA
-	ESCITALOPRAM OXALATE	tablet, film coated	0456-2006DRUG FOR FURTHER PROCESSING
-	ESCITALOPRAM OXALATE	tablet, film coated	0456-2011DRUG FOR FURTHER PROCESSING
-	ESCITALOPRAM OXALATE	tablet, film coated	0456-2021DRUG FOR FURTHER PROCESSING
ESTRACE	estradiol	cream, vaginal	0430-3754ANDA
Essential Defense Everyday Clear Broad Spectrum SPF 47 Sunscreen	Zinc Oxide and Octinoxate	lotion, topical	0023-5738OTC MONOGRAPH DRUG
Essential Defense Mineral Shield Broad Spectrum SPF 32 Sunscreen TINTED	Titanium Dioxide and Zinc Oxide	lotion, topical	0023-5675OTC MONOGRAPH DRUG
Essential Defense Mineral Shield Broad Spectrum SPF 35 Sunscreen	Titanium Dioxide and Zinc oxide	lotion, topical	0023-5703OTC MONOGRAPH DRUG
FML	fluorometholone	suspension/ drops, ophthalmic	11980-211NDA
FML FORTE	fluorometholone	suspension/ drops, ophthalmic	11980-228NDA
Fetzima	LEVOMILNACIPRAN HYDROCHLORIDE	kit, oral	0456-2200NDA
Fetzima	LEVOMILNACIPRAN HYDROCHLORIDE	kit, oral	0456-2202NDA
Fetzima	LEVOMILNACIPRAN HYDROCHLORIDE	capsule, extended release, oral	0456-2212NDA
Fetzima	LEVOMILNACIPRAN HYDROCHLORIDE	capsule, extended release, oral	0456-2220NDA
Fetzima	LEVOMILNACIPRAN HYDROCHLORIDE	capsule, extended release, oral	0456-2240NDA
Fetzima	LEVOMILNACIPRAN HYDROCHLORIDE	capsule, extended release, oral	0456-2280NDA
INFeD	Iron Dextran	injection, intramuscular, intravenous	0023-6082NDA
LASTACAFT	alcaftadine	solution/ drops, ophthalmic	0023-4290NDA
LASTACAFT	alcaftadine	solution/ drops, ophthalmic	0023-4291NDA
LATISSE	bimatoprost	solution/ drops, ophthalmic	0023-3616NDA
LILETTA	Levonorgestrel	intrauterine device, intrauterine	0023-5858NDA
LUMIGAN	bimatoprost	solution/ drops, ophthalmic	0023-3205NDA
Lexapro	ESCITALOPRAM	tablet, film coated, oral	0456-2005NDA
Lexapro	ESCITALOPRAM	tablet, film coated, oral	0456-2010NDA
Lexapro	ESCITALOPRAM	tablet, film coated, oral	0456-2020NDA
Linzess	linaclotide	capsule, gelatin coated, oral	0456-1201NDA
Linzess	linaclotide	capsule, gelatin coated, oral	0456-1202NDA
Linzess	linaclotide	capsule, gelatin coated, oral	0456-1203NDA
Lo Loestrin Fe	norethindrone acetate and ethinyl estradiol, ethinyl estradiol and ferrous fumarate	kit	0430-0420NDA
Namzaric	memantine hydrochloride and donepezil hydrochloride	capsule, oral	0456-1207NDA
Namzaric	memantine hydrochloride and donepezil hydrochloride	capsule, oral	0456-1214NDA
Namzaric	memantine hydrochloride and donepezil hydrochloride	capsule, oral	0456-1221NDA
Namzaric	memantine hydrochloride and donepezil hydrochloride	capsule, oral	0456-1228NDA
OCUFLOX	ofloxacin	solution/ drops, ophthalmic	11980-779NDA
OXYTROL	Oxybutynin	patch, transdermal	0023-6153NDA
OZURDEX	dexamethasone	implant, intravitreal	0023-3348NDA
OcuMend Healing Gels	Arnica Montana and Ledum Palustre Twig	patch, topical	0023-6934UNAPPROVED HOMEOPATHIC
Oxytrol for Women	Oxybutynin	patch, transdermal	0023-9637NDA
PRED FORTE	prednisolone acetate	suspension/ drops, ophthalmic	11980-180NDA
PRED MILD	prednisolone acetate	suspension/ drops, ophthalmic	11980-174NDA
REFRESH CELLUVISC	carboxymethylcellulose sodium	gel, ophthalmic	0023-4554OTC MONOGRAPH DRUG
REFRESH Classic	Polyvinyl Alcohol, Povidone	solution/ drops, ophthalmic	0023-0506OTC MONOGRAPH DRUG
REFRESH LACRI-LUBE	mineral oil, petrolatum	ointment, ophthalmic	0023-0312OTC MONOGRAPH DRUG
REFRESH LIQUIGEL	Carboxymethylcellulose sodium	gel, ophthalmic	0023-9205OTC MONOGRAPH DRUG
REFRESH OPTIVE	carboxymethylcellulose sodium and glycerin	solution/ drops, ophthalmic	0023-3240OTC MONOGRAPH DRUG
REFRESH OPTIVE Advanced	carboxymethylcellulose sodium, glycerin, and polysorbate 80	solution/ drops, ophthalmic	0023-4307OTC MONOGRAPH DRUG
REFRESH OPTIVE Advanced	carboxymethylcellulose sodium, glycerin, polysorbate 80	solution/ drops, ophthalmic	0023-4491OTC MONOGRAPH DRUG
REFRESH OPTIVE Drops	carboxymethylcellulose sodium and glycerin	solution/ drops, ophthalmic	0023-5459OTC MONOGRAPH DRUG
REFRESH Optive Mega-3	Carboxymethylcellulose sodium, Glycerin and Polysorbate 80	solution/ drops, ophthalmic	0023-4230OTC MONOGRAPH DRUG
REFRESH Optive Mega-3	Carboxymethylcellulose sodium, Glycerin and Polysorbate 80	solution/ drops, ophthalmic	0023-5773OTC MONOGRAPH DRUG
REFRESH Optive Mega-3	Carboxymethylcellulose sodium, Glycerin and Polysorbate 80	solution/ drops, ophthalmic	0023-7151OTC MONOGRAPH DRUG
REFRESH P.M.	mineral oil, petrolatum	ointment, ophthalmic	0023-0240OTC MONOGRAPH DRUG
REFRESH P.M.	mineral oil, petrolatum	ointment, ophthalmic	0023-0667OTC MONOGRAPH DRUG
REFRESH PLUS	carboxymethylcellulose sodium	solution/ drops, ophthalmic	0023-0403OTC MONOGRAPH DRUG
REFRESH TEARS	Carboxymethylcellulose sodium	kit	0023-0795OTC MONOGRAPH DRUG
REFRESH TEARS	carboxymethylcellulose sodium	solution/ drops, ophthalmic	0023-0798OTC MONOGRAPH DRUG
REFRESH TEARS PF	carboxymethylcellulose sodium, Glycerin	solution/ drops, ophthalmic	0023-3110OTC MONOGRAPH DRUG
RESTASIS	cyclosporine	emulsion, ophthalmic	0023-9163NDA
Rectiv	nitroglycerin	ointment, rectal	58914-301NDA
Refresh Digital	Carboxymethylcellulose sodium, Glycerin, Polysorbate 80	solution/ drops, ophthalmic	0023-6952OTC MONOGRAPH DRUG
Refresh Digital PF	Carboxymethylcellulose sodium, Glycerin and Polysorbate 80	solution/ drops, ophthalmic	0023-6954OTC MONOGRAPH DRUG
Refresh Optive	Carboxymethylcellulose Sodium, Glycerin	solution/ drops, ophthalmic	0023-3416OTC MONOGRAPH DRUG
Refresh Optive Mega-3 PF	carboxymethylcellulose sodium, Glycerin, Polysorbate 80	solution/ drops, ophthalmic	0023-3988OTC MONOGRAPH DRUG
Refresh RELIEVA PF	Carboxymethylcellulose sodium and Glycerin	solution/ drops, ophthalmic	0023-4515OTC MONOGRAPH DRUG
Refresh RELIEVA PF	Carboxymethylcellulose sodium and Glycerin	solution/ drops, ophthalmic	0023-9537OTC MONOGRAPH DRUG
Refresh Relieva	Carboxymethylcellulose sodium, Glycerin	solution/ drops, ophthalmic	0023-6630OTC MONOGRAPH DRUG
Refresh Relieva PF Xtra	Carboxymethylcellulose Sodium and Glycerin	solution/ drops, ophthalmic	0023-3782OTC MONOGRAPH DRUG
Refresh Relieva Preservative Free	Carboxymethylcellulose sodium and Glycerin	solution/ drops, ophthalmic	0023-6634OTC MONOGRAPH DRUG
Restasis MultiDose	cyclosporine	emulsion, ophthalmic	0023-5301NDA
-	Risedronate Sodium	tablet, film coated	0430-0473DRUG FOR FURTHER PROCESSING
-	Risedronate Sodium	tablet, film coated	0430-0487DRUG FOR FURTHER PROCESSING
SAPHRIS	Asenapine Maleate	tablet, sublingual	0456-2402NDA
SAPHRIS	Asenapine Maleate	tablet, sublingual	0456-2405NDA
SAPHRIS	Asenapine Maleate	tablet, sublingual	0456-2410NDA
SKIN MEDICA Purifying Foaming Wash	salicylic acid	liquid, topical	0023-4948OTC MONOGRAPH DRUG
Savella	milnacipran hydrochloride	kit, oral	0456-1500NDA
Savella	milnacipran hydrochloride	tablet, film coated, oral	0456-1510NDA
Savella	milnacipran hydrochloride	tablet, film coated, oral	0456-1512NDA
Savella	milnacipran hydrochloride	tablet, film coated, oral	0456-1525NDA
Savella	milnacipran hydrochloride	tablet, film coated, oral	0456-1550NDA
SkinMedica Acne Clarifying Treatment	Salicylic Acid	lotion, topical	0023-1230OTC MONOGRAPH DRUG
TOTAL DEFENSE REPAIR BROAD SPECTRUM SPF 34 Sunscreen	Octinoxate, Octisalate and Zinc Oxide	lotion, topical	0023-5494OTC MONOGRAPH DRUG
TOTAL DEFENSE REPAIR BROAD SPECTRUM SPF 34 Sunscreen (Tinted)	Octinoxate, Octisalate, Titanium dioxide and Zinc Oxide	lotion, topical	0023-5497OTC MONOGRAPH DRUG
Taytulla	norethindrone acetate and ethinyl estradiol, and ferrous fumarate	kit	0023-5862NDA
Teflaro	ceftaroline fosamil	powder, for solution, intravenous	0456-0400NDA
Teflaro	ceftaroline fosamil	powder, for solution, intravenous	0456-0600NDA
UBRELVY	ubrogepant	tablet, oral	0023-6498NDA
UBRELVY	ubrogepant	tablet, oral	0023-6501NDA
Urso 250	Ursodiol	tablet, film coated, oral	58914-785NDA
Urso Forte	Ursodiol	tablet, film coated, oral	58914-790NDA
VIIBRYD	vilazodone hydrochloride	tablet, oral	0456-1110NDA
VIIBRYD	vilazodone hydrochloride	tablet, oral	0456-1120NDA
VIIBRYD	vilazodone hydrochloride	tablet, oral	0456-1140NDA
Viberzi	Eluxadoline	tablet, film coated, oral	61874-075NDA
Viberzi	Eluxadoline	tablet, film coated, oral	61874-100NDA
Vraylar	cariprazine	capsule, gelatin coated, oral	61874-115NDA
Vraylar	cariprazine	capsule, gelatin coated, oral	61874-130NDA
Vraylar	cariprazine	capsule, gelatin coated, oral	61874-145NDA
Vraylar	cariprazine	capsule, gelatin coated, oral	61874-160NDA
Vraylar	cariprazine	kit, oral	61874-170NDA
Vraylar	cariprazine	capsule, gelatin coated, oral	61874-250NDA
Vraylar	cariprazine	capsule, gelatin coated, oral	61874-275NDA
ZYMAXID	gatifloxacin	solution/ drops, ophthalmic	0023-3615NDA
-	botulinum toxin type A	liquid	0023-1111BULK INGREDIENT
-	botulinum toxin type a	powder	0023-5028DRUG FOR FURTHER PROCESSING
-	cariprazine	capsule, gelatin coated	61874-116DRUG FOR FURTHER PROCESSING
-	cariprazine	capsule, gelatin coated	61874-131DRUG FOR FURTHER PROCESSING

Neighbours

Registered in the same town

PETNET Solutions, Inc.Cincinnati, OH · 2 sites
Spectrum Pharmaceuticals, Inc.Irvine, CA · 2 sites
Patheon Manufacturing Services LLCCincinnati, OH
Pharmalogic Holdings Corp.Cincinnati, OH
Siegfried USA, LLCIrvine, CA
Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.Dublin, IRL
Astellas Pharma US, Inc.DUBLIN, IRL
Takeda Pharmaceuticals U.S.A., Inc.Dublin, IRL
CAD IMPORT, INC.Cincinnati, OH
LGM Pharma Solutions, LLCIrvine, CA
North American Science Associates, LLCIrvine, CA
West Pharmaceutical Services, Inc.Dublin, IRL

Compare

Comparable companies in United States

Kenvue Brands LLC7 sites · 564 NDC
Hospira, Inc.7 sites · 332 NDC
Reckitt Benckiser LLC7 sites · 174 NDC
AGC Biologics, Inc.7 sites · 12 NDC
Central-McGowan, Inc.7 sites · 2 NDC
UCG Georgia, LLC7 sites · 2 NDC
Sanford Healthcare Accessories, LLC7 sites · 1 NDC
Fresenius Kabi USA, LLC6 sites · 561 NDC
Haleon US Holdings LLC8 sites · 405 NDC
Spectrum Pharmaceuticals, Inc.6 sites · 240 NDC

Enquiry

Common questions

Is Allergan, Inc. FDA approved?: Allergan, Inc. holds 7 FDA-registered establishments across 3 countries. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Allergan, Inc.'s drugs manufactured?: At registered sites in Belgium, Ireland, the United States. The FDA register lists Gr�ce-Hollogne; Carrowbeg Castlebar Road; Dublin; Campbell, CA; Cincinnati, OH; Irvine, CA, and 1 more. Registered operations: analytical testing, active ingredient (API) manufacture, labelling, finished drug manufacture, packaging.
What drugs does Allergan, Inc. make?: 187 products are listed under Allergan, Inc. in the openFDA NDC Directory, most often as tablet; solution/ drops; tablet, film coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.